MetLife Investment Management’s Surmodics SRDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $241K | Hold |
8,107
| – | – | ﹤0.01% | 2090 |
|
2025
Q1 | $248K | Sell |
8,107
-175
| -2% | -$5.34K | ﹤0.01% | 2085 |
|
2024
Q4 | $328K | Hold |
8,282
| – | – | ﹤0.01% | 2020 |
|
2024
Q3 | $321K | Hold |
8,282
| – | – | ﹤0.01% | 2024 |
|
2024
Q2 | $348K | Buy |
8,282
+777
| +10% | +$32.7K | ﹤0.01% | 1930 |
|
2024
Q1 | $220K | Hold |
7,505
| – | – | ﹤0.01% | 2147 |
|
2023
Q4 | $273K | Hold |
7,505
| – | – | ﹤0.01% | 2061 |
|
2023
Q3 | $241K | Hold |
7,505
| – | – | ﹤0.01% | 2095 |
|
2023
Q2 | $235K | Hold |
7,505
| – | – | ﹤0.01% | 2174 |
|
2023
Q1 | $171K | Hold |
7,505
| – | – | ﹤0.01% | 2311 |
|
2022
Q4 | $256K | Hold |
7,505
| – | – | ﹤0.01% | 2094 |
|
2022
Q3 | $228K | Hold |
7,505
| – | – | ﹤0.01% | 2208 |
|
2022
Q2 | $279K | Hold |
7,505
| – | – | ﹤0.01% | 2062 |
|
2022
Q1 | $340K | Buy |
7,505
+2,758
| +58% | +$125K | ﹤0.01% | 2023 |
|
2021
Q4 | $229K | Hold |
4,747
| – | – | ﹤0.01% | 1973 |
|
2021
Q3 | $264K | Sell |
4,747
-1,412
| -23% | -$78.5K | ﹤0.01% | 1907 |
|
2021
Q2 | $334K | Hold |
6,159
| – | – | ﹤0.01% | 1821 |
|
2021
Q1 | $345K | Hold |
6,159
| – | – | ﹤0.01% | 1735 |
|
2020
Q4 | $268K | Hold |
6,159
| – | – | ﹤0.01% | 1827 |
|
2020
Q3 | $240K | Hold |
6,159
| – | – | ﹤0.01% | 1755 |
|
2020
Q2 | $266K | Hold |
6,159
| – | – | ﹤0.01% | 1730 |
|
2020
Q1 | $205K | Hold |
6,159
| – | – | ﹤0.01% | 1681 |
|
2019
Q4 | $255K | Hold |
6,159
| – | – | ﹤0.01% | 1843 |
|
2019
Q3 | $282K | Hold |
6,159
| – | – | ﹤0.01% | 1744 |
|
2019
Q2 | $266K | Hold |
6,159
| – | – | ﹤0.01% | 1866 |
|
2019
Q1 | $268K | Hold |
6,159
| – | – | ﹤0.01% | 1819 |
|
2018
Q4 | $291K | Hold |
6,159
| – | – | ﹤0.01% | 1696 |
|
2018
Q3 | $460K | Hold |
6,159
| – | – | ﹤0.01% | 1590 |
|
2018
Q2 | $340K | Hold |
6,159
| – | – | ﹤0.01% | 1643 |
|
2018
Q1 | $234K | Hold |
6,159
| – | – | ﹤0.01% | 1805 |
|
2017
Q4 | $172K | Buy |
+6,159
| New | +$172K | ﹤0.01% | 2007 |
|